![]() |
市场调查报告书
商品编码
1561543
2024-2032 年冷冻治疗市场报告(按产品、应用、最终用户和地区划分)Cryotherapy Market Report by Product, Application, End User, and Region 2024-2032 |
2023年全球冷冻治疗IMARC Group规模达3.299亿美元。老年人口的成长、癌症盛行率的增加以及焦虑、气喘、偏头痛和肌肉酸痛病例的增加是推动市场发展的一些关键因素。
冷冻疗法是指依赖极低温度进行治疗的医学疗法。它有助于减少身体疼痛,并透过促进胶原蛋白的产生来改善皮肤健康和质地。它还可以透过增加体内白血球的水平来帮助增强免疫功能。此外,冷冻疗法透过收缩头部血管和减少发炎来帮助缓解偏头痛和头痛。它用于治疗多种疾病,包括运动伤害、关节炎、皮肤病和慢性疼痛。运动员也用它来治疗运动伤害,例如肌肉拉伤,帮助加快受伤后的恢復时间并提高表现。
目前,体育健身活动的日益普及,导致运动伤害的发生率不断上升。这是积极影响全球市场的关键因素之一。此外,不断增长的老年人口和不断增加的癌症盛行率正在推动对冷冻疗法的需求,以实现快速康復、减少併发症和最大限度地缩短住院时间。再加上久坐的生活方式、不健康的饮食模式以及不断增加的焦虑、气喘、偏头痛和肌肉酸痛病例,正在创造一个有利的市场前景。除此之外,社群媒体的影响力不断增强,人们对健康和美容疗程的兴趣日益浓厚,再加上对皮肤病非侵入性治疗的日益青睐,正在加强市场的成长。此外,对具有成本效益的治疗方案的需求不断增长,刺激了对冷冻疗法的需求,作为更昂贵的治疗(例如手术)的潜在替代方案。与此一致的是,用于治疗发炎、类风湿性关节炎和慢性疼痛的冷冻室和冷冻桑拿室的开发正在推动市场的成长。此外,冷冻疗法的可近性和可负担性的提高也促进了市场的成长。此外,医疗保健基础设施的显着改善以及对研发 (R&D) 活动的广泛投资正在推动全球市场的成长。 ,以及蓬勃发展的健康和健身产业。
The global cryotherapy market size reached US$ 329.9 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 539.8 Million by 2032, exhibiting a growth rate (CAGR) of 5.5% during 2024-2032. The growing geriatric population, increasing prevalence of cancer and increasing cases of anxiety, asthma, migraine, and muscle soreness represent some of the key factors driving the market.
Cryotherapy refers to a medical therapy that relies on extremely low temperatures for treatment. It helps reduce pain in the body and improves skin health and texture by promoting collagen production. It also helps boost immune function by increasing levels of white blood cells in the body. Moreover, cryotherapy aids in relieving migraines and headaches by constricting blood vessels in the head and reducing inflammation. It is employed to treat a variety of medical conditions, including sports injuries, arthritis, skin conditions, and chronic pain. It is also used by athletes to treat sports injuries, such as muscle strains, help speed up recovery time after injury, and improve performance.
At present, the growing popularity of sports and fitness activities is resulting in the increasing incidence of sports injuries. This represents one of the key factors positively influencing the market across the globe. In addition, the growing geriatric population and increasing prevalence of cancer are catalyzing the demand for cryotherapy for fast recovering, reducing complications, and minimizing hospital stays. This, in confluence with sedentary lifestyles, unhealthy dietary patterns, and increasing cases of anxiety, asthma, migraine, and muscle soreness, is creating a favorable market outlook. Apart from this, the rising influence of social media and the growing interest in wellness and beauty treatments, in confluence with the increasing preference for non-invasive treatments for skin conditions, is strengthening the market growth. Moreover, the rising demand for cost-effective treatment options is catalyzing the demand for cryotherapy as a potential alternative to more expensive treatments, such as surgeries. In line with this, the development of cryo-chambers and cryo-saunas for the treatment of inflammation, rheumatoid arthritis, and chronic pain, are fueling the market growth. Additionally, the increasing accessibility and the rising affordability of cryotherapy are contributing to the market growth. Furthermore, significant improvements in the healthcare infrastructure, along with extensive investments in research and development (R&D) activities, are fueling the growth of the market worldwide., Some of the other factors stimulating the growth of the market across the globe include inflating disposable incomes, increasing awareness about the benefits of cryotherapy, and flourishing wellness and fitness industries.
IMARC Group provides an analysis of the key trends in each sub-segment of the global cryotherapy market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, application and end user.
The report has provided a detailed breakup and analysis of the cryotherapy market based on the product. This includes cryosurgery devices (tissue contact probes, tissue spray probes, epidermal and subcutaneous cryoablation devices), localized cryotherapy devices, and cryochambers and cryosaunas. According to the report, cryochambers and cryosaunas accounted for the largest market share.
A detailed breakup and analysis of the cryotherapy market based on the application has also been provided in the report. This includes surgical applications (oncology, cardiology, dermatology, and others), pain management, and recovery, health and beauty. According to the report, pain management accounted for the largest market share.
A detailed breakup and analysis of the cryotherapy market based on the end user has also been provided in the report. This includes hospitals and specialty clinics, cryotherapy centres, spas and fitness centres. According to the report, cryotherapy centres accounted for the largest market share.
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for cryotherapy. Some of the factors driving the North America cryotherapy market included the high disposable incomes, increasing incidences of sports injuries, rising awareness about the benefits of cryotherapy on skin conditions, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global cryotherapy market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Boston Scientific Corporation, Brymill Cryogenic Systems, CooperSurgical Inc., Cortex Technology, CryoConcepts LP, Erbe Elektromedizin GmbH, Kriosystem-Care Sp. z o.o., Medtronic plc, METRUM CRYOFLEX Sp. z o.o. Sp. k., Pacira BioSciences Inc., US Cryotherapy, Zimmer MedizinSysteme GmbH, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.